Description: This project enhances the current understanding of cyber risks in the smart home ecosystem from the insurance industry's perspective. In particular, the quantitative framework and pricing strategies developed in this project can be immediately adopted/adapted by actuaries to price the cyber risks for smart homes, a fast-growing insurance market.

Description: This report documents updates to the Canadian mortality data in both the Human Mortality Database and the Canadian Human Mortality Database, including new data for 2022–2023.

Description: Anti-obesity medications have been met with reluctance from payers and employee benefits consultants who often lack analogs or empirical data to estimate the cost impact of new therapies coverage. Health plans considering coverage of anti-obesity medications will need to assess and manage the potential costs of covering these new therapies in context of their overall obesity management strategy, including coverage of nutrition counseling, weight management, and bariatric surgery.

Description: This session will bring together public health care leaders in COVID-10 vaccine delivery from both the U.S. and the UK to discuss and compare operational implications of the COVID-19 vaccine rollout in their countries, and how those programs ultimately affected hospitalization utilization and mortality rates for members of their communities.

Description: While our ability to access and analyze large quantities of data is better than ever, many long-term products suffer from sparse data in critical risk areas, such as deep in-the-money lapse experience and long-term utilization rates for income guarantees. The presenters will explore industry-level annuity experience data for these types of situations, and discuss quantitative approaches to addressing them in pricing and other applications.

Description: The presenters will address innovations in health and wellness designed to mitigate and/or manage mortality risk. The presenters will briefly review the latest research on the leading causes of death and share ways that life insurers and insurtech partnerships are using technology, customer engagement and scientific advances to enhance/extend the lives of policyholders. The presenters will draw from industry research and reinsurer studies and from the latest initiatives in health and wellness innovations.

Description: This intercompany study examines expenses by type of expense, distribution channel, and type of policy.

Description: The 2009 Estonia experience study includes both mortality and persistency studies of policies in force any time during the 2006-2008 study period. The study applies to the entire portfolios of the contributing companies and these companies represent the vast majority of the Estonia individual life insurance market. Separate studies were performed based upon policy counts and insurance in force. Actual mortality was compared to expected mortality based upon the SOA 1975-80 select and ultimate mortality table.

Description: Recent research from Financial Finesse introduces a viable way to forecast the potential return on investment (ROI) of workplace financial wellness programs.